FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011026300> ?p ?o ?g. }

• W2011026300 endingPage "545" @default.
• W2011026300 startingPage "539" @default.
• W2011026300 abstract "Dysregulation of the hedgehog signaling pathway has been linked to the development and progression of a variety of different human tumors including cancers of the skin, brain, colon, prostate, blood, and pancreas. We assessed the clinicopathological factors that are potentially related to expression of Gli1, the transcription factor that is thought to be the most reliable marker of hedgehog pathway activation in bladder cancer.Bladder cancer cases were identified from the New Hampshire State Cancer Registry as histologically confirmed primary bladder cancer diagnosed between January 1, 2002, and July 31, 2004. Immunohistochemical analysis was performed on a tissue microarray to detect Gli1 and p53 expression in these bladder tumors. We computed odds ratios (ORs) and their 95% CIs for Gli1 positivity for pathological category using T category (from TNM), invasiveness, and grade with both the World Health Organization 1973 and World Health Organization International Society of Urological Pathology criteria. We calculated hazard ratios and their 95% CI for Gli1 positivity and recurrence for both Ta-category and invasive bladder tumors (T1+).A total of 194 men and 67 women, whose tumors were assessable for Gli1 staining, were included in the study. No appreciable differences in Gli1 staining were noted by sex, age, smoking status, or high-risk occupation. Ta-category tumors were more likely to stain for Gli1 as compared with T1-category tumors (adjusted OR = 0.38, CI: 0.17-0.87). Similarly, low-grade (grades 1-2) tumors were more likely to stain for Gli1 as compared with high-grade tumors (grade 3) (adjusted OR = 0.44, CI: 0.21-0.93). In a Cox proportional hazards regression analysis, non-muscle-invasive bladder tumors expressing Gli1 were less likely to recur (adjusted hazard ratio = 0.48; CI: 0.28-0.82; P<0.05) than those in which Gli1 was absent.Our findings indicate that Gli1 expression may be a marker of low-stage, low-grade bladder tumors and an indicator of a reduced risk of recurrence in this group." @default.
• W2011026300 created "2016-06-24" @default.
• W2011026300 creator A5001227908 @default.
• W2011026300 creator A5007112244 @default.
• W2011026300 creator A5023472431 @default.
• W2011026300 creator A5031516173 @default.
• W2011026300 creator A5034736070 @default.
• W2011026300 creator A5040549181 @default.
• W2011026300 creator A5050569417 @default.
• W2011026300 creator A5050881727 @default.
• W2011026300 creator A5062649421 @default.
• W2011026300 creator A5081568154 @default.
• W2011026300 creator A5088746992 @default.
• W2011026300 date "2014-07-01" @default.
• W2011026300 modified "2023-10-02" @default.
• W2011026300 title "Clinicopathological correlates of Gli1 expression in a population-based cohort of patients with newly diagnosed bladder cancer" @default.
• W2011026300 cites W1964290462 @default.
• W2011026300 cites W2012356922 @default.
• W2011026300 cites W2012526118 @default.
• W2011026300 cites W2045104540 @default.
• W2011026300 cites W2063651596 @default.
• W2011026300 cites W2070773287 @default.
• W2011026300 cites W2088342479 @default.
• W2011026300 cites W2093550274 @default.
• W2011026300 cites W2097935950 @default.
• W2011026300 cites W2099118069 @default.
• W2011026300 cites W2117692326 @default.
• W2011026300 cites W2132311725 @default.
• W2011026300 cites W2133646931 @default.
• W2011026300 cites W2137471416 @default.
• W2011026300 cites W2148802044 @default.
• W2011026300 cites W2155829623 @default.
• W2011026300 cites W2161566367 @default.
• W2011026300 cites W2275614507 @default.
• W2011026300 cites W2328287054 @default.
• W2011026300 doi "https://doi.org/10.1016/j.urolonc.2014.03.006" @default.
• W2011026300 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4243987" @default.
• W2011026300 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24856810" @default.
• W2011026300 hasPublicationYear "2014" @default.
• W2011026300 type Work @default.
• W2011026300 sameAs 2011026300 @default.
• W2011026300 citedByCount "12" @default.
• W2011026300 countsByYear W20110263002014 @default.
• W2011026300 countsByYear W20110263002016 @default.
• W2011026300 countsByYear W20110263002017 @default.
• W2011026300 countsByYear W20110263002018 @default.
• W2011026300 countsByYear W20110263002019 @default.
• W2011026300 countsByYear W20110263002021 @default.
• W2011026300 countsByYear W20110263002022 @default.
• W2011026300 countsByYear W20110263002023 @default.
• W2011026300 crossrefType "journal-article" @default.
• W2011026300 hasAuthorship W2011026300A5001227908 @default.
• W2011026300 hasAuthorship W2011026300A5007112244 @default.
• W2011026300 hasAuthorship W2011026300A5023472431 @default.
• W2011026300 hasAuthorship W2011026300A5031516173 @default.
• W2011026300 hasAuthorship W2011026300A5034736070 @default.
• W2011026300 hasAuthorship W2011026300A5040549181 @default.
• W2011026300 hasAuthorship W2011026300A5050569417 @default.
• W2011026300 hasAuthorship W2011026300A5050881727 @default.
• W2011026300 hasAuthorship W2011026300A5062649421 @default.
• W2011026300 hasAuthorship W2011026300A5081568154 @default.
• W2011026300 hasAuthorship W2011026300A5088746992 @default.
• W2011026300 hasBestOaLocation W20110263002 @default.
• W2011026300 hasConcept C104317684 @default.
• W2011026300 hasConcept C121608353 @default.
• W2011026300 hasConcept C126322002 @default.
• W2011026300 hasConcept C142724271 @default.
• W2011026300 hasConcept C143998085 @default.
• W2011026300 hasConcept C156957248 @default.
• W2011026300 hasConcept C193270364 @default.
• W2011026300 hasConcept C207886595 @default.
• W2011026300 hasConcept C2778539099 @default.
• W2011026300 hasConcept C2779933373 @default.
• W2011026300 hasConcept C2780352672 @default.
• W2011026300 hasConcept C2908647359 @default.
• W2011026300 hasConcept C50440223 @default.
• W2011026300 hasConcept C55493867 @default.
• W2011026300 hasConcept C71924100 @default.
• W2011026300 hasConcept C86803240 @default.
• W2011026300 hasConcept C99454951 @default.
• W2011026300 hasConceptScore W2011026300C104317684 @default.
• W2011026300 hasConceptScore W2011026300C121608353 @default.
• W2011026300 hasConceptScore W2011026300C126322002 @default.
• W2011026300 hasConceptScore W2011026300C142724271 @default.
• W2011026300 hasConceptScore W2011026300C143998085 @default.
• W2011026300 hasConceptScore W2011026300C156957248 @default.
• W2011026300 hasConceptScore W2011026300C193270364 @default.
• W2011026300 hasConceptScore W2011026300C207886595 @default.
• W2011026300 hasConceptScore W2011026300C2778539099 @default.
• W2011026300 hasConceptScore W2011026300C2779933373 @default.
• W2011026300 hasConceptScore W2011026300C2780352672 @default.
• W2011026300 hasConceptScore W2011026300C2908647359 @default.
• W2011026300 hasConceptScore W2011026300C50440223 @default.
• W2011026300 hasConceptScore W2011026300C55493867 @default.
• W2011026300 hasConceptScore W2011026300C71924100 @default.
• W2011026300 hasConceptScore W2011026300C86803240 @default.
• W2011026300 hasConceptScore W2011026300C99454951 @default.
• W2011026300 hasIssue "5" @default.

• next